NeoGenomics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NeoGenomics and other ETFs, options, and stocks.About NEO
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T.
NEO Key Statistics
Stock Snapshot
NeoGenomics(NEO) stock is priced at $17.27, giving the company a market capitalization of 2.22B. It carries a P/E multiple of -41.37.
On 2026-10-27, NeoGenomics(NEO) stock moved within a range of $16.61 to $17.48. With shares now at $17.27, the stock is trading +4.0% above its intraday low and -1.2% below the session's peak.
Trading activity shows a volume of 2.71M, compared to an average daily volume of 1.66M.
The stock's 52-week range extends from a low of $7.07 to a high of $20.15.
The stock's 52-week range extends from a low of $7.07 to a high of $20.15.
NEO News
has had a mixed share price record over the past few years, and the question now is whether the current US$16.59 level can be squared with what the business is...
Analyst ratings
75%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.